Creon (Page 6 of 6)

NDC 0032-1203-70

70 Capsules

CREON® (pancrelipase) Delayed-Release Capsules

DOSE BY LIPASE UNITS: Lipase 3,000 USP Units, Protease 9,500 USP Units, Amylase 15,000 USP Units

Each capsule contains pancrelipase in enteric-coated spheres.

PHARMACIST: DISPENSE IN ORIGINAL CONTAINER

Dispense enclosed Medication Guide to each patient.

Rx only

abbvie

NDC 0032-1203-70 70 Capsules CREON® (pancrelipase) Delayed-Release Capsules DOSE BY LIPASE UNITS: Lipase 3,000 USP Units, Protease 9,500 USP Units, Amylase 15,000 USP Units Each capsule contains pancrelipase in enteric-coated spheres. PHARMACIST: DISPENSE IN ORIGINAL CONTAINER Dispense enclosed Medication Guide to each patient. Rx only abbvie
(click image for full-size original)

NDC 0032-1206-01

100 Capsules

CREON® (pancrelipase) Delayed-Release Capsules

DOSE BY LIPASE UNITS: Lipase 6,000 USP Units, Protease 19,000 USP Units, Amylase 30,000 USP Units

Each capsule contains pancrelipase in enteric-coated spheres.

Dispense enclosed Medication Guide to each patient.

Rx only

abbvie

NDC 0032-1206-01 100 Capsules CREON® (pancrelipase) Delayed-Release Capsules DOSE BY LIPASE UNITS: Lipase 6,000 USP Units, Protease 19,000 USP Units, Amylase 30,000 USP Units Each capsule contains pancrelipase in enteric-coated spheres. Dispense enclosed Medication Guide to each patient. Rx only abbvie
(click image for full-size original)

250 Capsules

NDC 0032-1206-07

CREON® (pancrelipase) Delayed-Release Capsules

DOSE BY LIPASE UNITS: Lipase 6,000 USP Units, Protease 19,000 USP Units, Amylase 30,000 USP Units

Each capsule contains pancrelipase in enteric-coated spheres.

Dispense enclosed Medication Guide to each patient.

Rx only

abbvie

250 Capsules NDC 0032-1206-07 CREON® (pancrelipase) Delayed-Release Capsules DOSE BY LIPASE UNITS: Lipase 6,000 USP Units, Protease 19,000 USP Units, Amylase 30,000 USP Units Each capsule contains pancrelipase in enteric-coated spheres. Dispense enclosed Medication Guide to each patient. Rx only abbvie
(click image for full-size original)

250 Capsules

NDC 0032-1212-07

CREON® (pancrelipase) Delayed-Release Capsules

DOSE BY LIPASE UNITS: Lipase 12,000 USP Units, Protease 38,000 USP Units, Amylase 60,000 USP Units

Each capsule contains pancrelipase in enteric-coated spheres.

Dispense enclosed Medication Guide to each patient.

Rx only

abbvie

250 Capsules NDC 0032-1212-07 CREON® (pancrelipase) Delayed-Release Capsules DOSE BY LIPASE UNITS: Lipase 12,000 USP Units, Protease 38,000 USP Units, Amylase 60,000 USP Units Each capsule contains pancrelipase in enteric-coated spheres. Dispense enclosed Medication Guide to each patient. Rx only abbvie
(click image for full-size original)

100 capsules

NDC 0032-1212-13

CREON® (pancrelipase) Delayed-Release Capsules

DOSE BY LIPASE UNITS: Lipase 12,000 USP Units, Protease 38,000 USP Units, Amylase 60,000 USP Units

Each capsule contains pancrelipase in enteric-coated spheres.

Dispense enclosed Medication Guide to each patient.

PROFESSIONAL SAMPLE

NOT FOR SALE

Rx only

abbvie

100 capsules NDC 0032-1212-13 CREON® (pancrelipase) Delayed-Release Capsules DOSE BY LIPASE UNITS: Lipase 12,000 USP Units, Protease 38,000 USP Units, Amylase 60,000 USP Units Each capsule contains pancrelipase in enteric-coated spheres. Dispense enclosed Medication Guide to each patient. PROFESSIONAL SAMPLE NOT FOR SALE Rx only abbvie
(click image for full-size original)

100 Capsules

NDC 0032-1224-01

CREON® (pancrelipase) Delayed-Release Capsules

DOSE BY LIPASE UNITS: Lipase 24,000 USP Units, Protease 76,000 USP Units, Amylase 120,000 USP Units

Each capsule contains pancrelipase in enteric-coated spheres.

Dispense enclosed Medication Guide to each patient.

Rx only

abbvie

100 Capsules NDC 0032-1224-01 CREON® (pancrelipase) Delayed-Release Capsules DOSE BY LIPASE UNITS: Lipase 24,000 USP Units, Protease 76,000 USP Units, Amylase 120,000 USP Units Each capsule contains pancrelipase in enteric-coated spheres. Dispense enclosed Medication Guide to each patient. Rx only abbvie
(click image for full-size original)

100 Capsules

NDC 0032-3016-13

CREON® (pancrelipase) Delayed-Release Capsules

DOSE BY LIPASE UNITS: Lipase 36,000 USP Units, Protease 114,000 USP Units, Amylase 180,000 USP Units

Each capsule contains pancrelipase in enteric-coated spheres.

Dispense enclosed Medication Guide to each patient.

Rx only

abbvie

100 Capsules NDC 0032-3016-13 CREON® (pancrelipase) Delayed-Release Capsules DOSE BY LIPASE UNITS: Lipase 36,000 USP Units, Protease 114,000 USP Units, Amylase 180,000 USP Units Each capsule contains pancrelipase in enteric-coated spheres. Dispense enclosed Medication Guide to each patient. Rx only abbvie
(click image for full-size original)

NDC 0032-3016-12

12 Capsules

CREON® (pancrelipase) Delayed-Release Capsules

DOSE BY LIPASE UNITS: Lipase 36,000 USP Units, Protease 114,000 USP Units, Amylase 180,000 USP Units

Each capsule contains pancrelipase in enteric-coated spheres.

Dispense enclosed Medication Guide to each patient.

Rx only

PROFESSIONAL SAMPLE

NOT FOR RESALE

abbvie

NDC 0032-3016-12 12 Capsules CREON® (pancrelipase) Delayed-Release Capsules DOSE BY LIPASE UNITS: Lipase 36,000 USP Units, Protease 114,000 USP Units, Amylase 180,000 USP Units Each capsule contains pancrelipase in enteric-coated spheres. Dispense enclosed Medication Guide to each patient. Rx only PROFESSIONAL SAMPLE NOT FOR RESALE abbvie
(click image for full-size original)
CREON pancrelipase capsule, delayed release pellets
Product Information
Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:0032-1206
Route of Administration ORAL DEA Schedule
Active Ingredient/Active Moiety
Ingredient Name Basis of Strength Strength
PANCRELIPASE AMYLASE (PANCRELIPASE AMYLASE) PANCRELIPASE AMYLASE 30000 [USP’U]
PANCRELIPASE LIPASE (PANCRELIPASE LIPASE) PANCRELIPASE LIPASE 6000 [USP’U]
PANCRELIPASE PROTEASE (PANCRELIPASE PROTEASE) PANCRELIPASE PROTEASE 19000 [USP’U]
Inactive Ingredients
Ingredient Name Strength
cetyl alcohol
dimethicone
HYPROMELLOSE PHTHALATE (31% PHTHALATE, 40 CST)
POLYETHYLENE GLYCOL, UNSPECIFIED
triethyl citrate
TITANIUM DIOXIDE
FD&C BLUE NO. 2
FERRIC OXIDE RED
SODIUM LAURYL SULFATE
FERRIC OXIDE YELLOW
GELATIN, UNSPECIFIED
Product Characteristics
Color blue (Blue opaque body) , orange (Orange opaque cap) Score no score
Shape CAPSULE (OVAL) Size 14mm
Flavor Imprint Code CREON;1206
Contains
Packaging
# Item Code Package Description Multilevel Packaging
1 NDC:0032-1206-07 250 CAPSULE, DELAYED RELEASE PELLETS in 1 BOTTLE None
2 NDC:0032-1206-01 1 BOTTLE in 1 CARTON contains a BOTTLE
2 100 CAPSULE, DELAYED RELEASE PELLETS in 1 BOTTLE This package is contained within the CARTON (0032-1206-01)
3 NDC:0032-1206-56 1 BOTTLE in 1 CARTON contains a BOTTLE
3 100 CAPSULE, DELAYED RELEASE PELLETS in 1 BOTTLE This package is contained within the CARTON (0032-1206-56)
Marketing Information
Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
BLA BLA020725 04/30/2009
CREON pancrelipase capsule, delayed release pellets
Product Information
Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:0032-1212
Route of Administration ORAL DEA Schedule
Active Ingredient/Active Moiety
Ingredient Name Basis of Strength Strength
PANCRELIPASE AMYLASE (PANCRELIPASE AMYLASE) PANCRELIPASE AMYLASE 60000 [USP’U]
PANCRELIPASE LIPASE (PANCRELIPASE LIPASE) PANCRELIPASE LIPASE 12000 [USP’U]
PANCRELIPASE PROTEASE (PANCRELIPASE PROTEASE) PANCRELIPASE PROTEASE 38000 [USP’U]
Inactive Ingredients
Ingredient Name Strength
FERROSOFERRIC OXIDE
GELATIN, UNSPECIFIED
FERRIC OXIDE RED
SODIUM LAURYL SULFATE
TITANIUM DIOXIDE
FERRIC OXIDE YELLOW
cetyl alcohol
dimethicone
HYPROMELLOSE PHTHALATE (31% PHTHALATE, 40 CST)
POLYETHYLENE GLYCOL, UNSPECIFIED
triethyl citrate
Product Characteristics
Color brown (Colorless transparent body and brown opaque cap) Score no score
Shape CAPSULE (OVAL) Size 18mm
Flavor Imprint Code CREON;1212
Contains
Packaging
# Item Code Package Description Multilevel Packaging
1 NDC:0032-1212-07 250 CAPSULE, DELAYED RELEASE PELLETS in 1 BOTTLE None
2 NDC:0032-1212-01 100 CAPSULE, DELAYED RELEASE PELLETS in 1 BOTTLE None
3 NDC:0032-1212-46 1 BOTTLE in 1 CARTON contains a BOTTLE
3 12 CAPSULE, DELAYED RELEASE PELLETS in 1 BOTTLE This package is contained within the CARTON (0032-1212-46)
4 NDC:0032-1212-13 1 BOTTLE in 1 CARTON contains a BOTTLE
4 100 CAPSULE, DELAYED RELEASE PELLETS in 1 BOTTLE This package is contained within the CARTON (0032-1212-13)
Marketing Information
Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
BLA BLA020725 04/30/2009
CREON pancrelipase capsule, delayed release pellets
Product Information
Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:0032-1224
Route of Administration ORAL DEA Schedule
Active Ingredient/Active Moiety
Ingredient Name Basis of Strength Strength
PANCRELIPASE LIPASE (PANCRELIPASE LIPASE) PANCRELIPASE LIPASE 24000 [USP’U]
PANCRELIPASE PROTEASE (PANCRELIPASE PROTEASE) PANCRELIPASE PROTEASE 76000 [USP’U]
PANCRELIPASE AMYLASE (PANCRELIPASE AMYLASE) PANCRELIPASE AMYLASE 120000 [USP’U]
Inactive Ingredients
Ingredient Name Strength
cetyl alcohol
dimethicone
triethyl citrate
FERRIC OXIDE RED
SODIUM LAURYL SULFATE
TITANIUM DIOXIDE
FERRIC OXIDE YELLOW
HYPROMELLOSE PHTHALATE (31% PHTHALATE, 40 CST)
POLYETHYLENE GLYCOL, UNSPECIFIED
GELATIN, UNSPECIFIED
Product Characteristics
Color orange (Colorless transparent body and orange opaque cap) Score no score
Shape CAPSULE (OVAL) Size 22mm
Flavor Imprint Code CREON;1224
Contains
Packaging
# Item Code Package Description Multilevel Packaging
1 NDC:0032-1224-07 250 CAPSULE, DELAYED RELEASE PELLETS in 1 BOTTLE None
2 NDC:0032-1224-01 100 CAPSULE, DELAYED RELEASE PELLETS in 1 BOTTLE None
3 NDC:0032-1224-46 1 BOTTLE in 1 CARTON contains a BOTTLE
3 12 CAPSULE, DELAYED RELEASE PELLETS in 1 BOTTLE This package is contained within the CARTON (0032-1224-46)
Marketing Information
Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
BLA BLA020725 04/30/2009
CREON pancrelipase capsule, delayed release
Product Information
Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:0032-1203
Route of Administration ORAL DEA Schedule
Active Ingredient/Active Moiety
Ingredient Name Basis of Strength Strength
PANCRELIPASE AMYLASE (PANCRELIPASE AMYLASE) PANCRELIPASE AMYLASE 15000 [USP’U]
PANCRELIPASE LIPASE (PANCRELIPASE LIPASE) PANCRELIPASE LIPASE 3000 [USP’U]
PANCRELIPASE PROTEASE (PANCRELIPASE PROTEASE) PANCRELIPASE PROTEASE 9500 [USP’U]
Inactive Ingredients
Ingredient Name Strength
cetyl alcohol
dimethicone
TITANIUM DIOXIDE
triethyl citrate
HYPROMELLOSE PHTHALATE (31% PHTHALATE, 40 CST)
POLYETHYLENE GLYCOL, UNSPECIFIED
HYPROMELLOSE, UNSPECIFIED
Product Characteristics
Color white (White opaque body and white opaque cap) Score no score
Shape CAPSULE (OVAL) Size 14mm
Flavor Imprint Code CREON;1203
Contains
Packaging
# Item Code Package Description Multilevel Packaging
1 NDC:0032-1203-70 1 BOTTLE in 1 CARTON contains a BOTTLE
1 70 CAPSULE, DELAYED RELEASE in 1 BOTTLE This package is contained within the CARTON (0032-1203-70)
2 NDC:0032-1203-64 1 BOTTLE in 1 CARTON contains a BOTTLE
2 70 CAPSULE, DELAYED RELEASE in 1 BOTTLE This package is contained within the CARTON (0032-1203-64)
Marketing Information
Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
BLA BLA020725 04/30/2009
CREON pancrelipase capsule, delayed release pellets
Product Information
Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:0032-3016
Route of Administration ORAL DEA Schedule
Active Ingredient/Active Moiety
Ingredient Name Basis of Strength Strength
PANCRELIPASE LIPASE (PANCRELIPASE LIPASE) PANCRELIPASE LIPASE 36000 [USP’U]
PANCRELIPASE AMYLASE (PANCRELIPASE AMYLASE) PANCRELIPASE AMYLASE 180000 [USP’U]
PANCRELIPASE PROTEASE (PANCRELIPASE PROTEASE) PANCRELIPASE PROTEASE 114000 [USP’U]
Inactive Ingredients
Ingredient Name Strength
HYPROMELLOSE PHTHALATE (31% PHTHALATE, 40 CST)
cetyl alcohol
dimethicone
triethyl citrate
TITANIUM DIOXIDE
FD&C BLUE NO. 2
SODIUM LAURYL SULFATE
POLYETHYLENE GLYCOL, UNSPECIFIED
GELATIN, UNSPECIFIED
Product Characteristics
Color blue (Colorless transparent body and blue opaque cap) Score no score
Shape CAPSULE (OVAL) Size 25mm
Flavor Imprint Code CREON;1236
Contains
Packaging
# Item Code Package Description Multilevel Packaging
1 NDC:0032-3016-28 250 CAPSULE, DELAYED RELEASE PELLETS in 1 BOTTLE None
2 NDC:0032-3016-13 100 CAPSULE, DELAYED RELEASE PELLETS in 1 BOTTLE None
3 NDC:0032-3016-50 50 CAPSULE, DELAYED RELEASE PELLETS in 1 BOTTLE None
4 NDC:0032-3016-12 1 BOTTLE in 1 CARTON contains a BOTTLE
4 12 CAPSULE, DELAYED RELEASE PELLETS in 1 BOTTLE This package is contained within the CARTON (0032-3016-12)
Marketing Information
Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
BLA BLA020725 03/14/2013
Labeler — AbbVie Inc. (078458370)

Revised: 06/2022 AbbVie Inc.

All MedLibrary.org resources are included in as near-original form as possible, meaning that the information from the original provider has been rendered here with only typographical or stylistic modifications and not with any substantive alterations of content, meaning or intent.

https://medlibrary.org/lib/rx/meds/creon/page/6/

Clinical Trials

MedLibrary.org

Medication Sections

RSS Feeds

About

This site is provided for educational and informational purposes only, in accordance with our Terms of Use, and is not intended as a substitute for the advice of a medical doctor, nurse, nurse practitioner or other qualified health professional.

Privacy Policy | Copyright © 2023. All Rights Reserved.